Biomarin Pharmaceutical (NASDAQ:BMRN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?

Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.

Open	$71.82
Close	$70.69
Volume / Avg.	3.40M / 2.23M
Day Range	$70.09 - $71.82
52 Wk Range	68.83 - 99.56
Market Cap	$13.46B
P/E Ratio	54.11
Dividend Yield	-
Exchange	NASDAQ
RSI	23
Short Interest	3.09%
Days to Cover	4.1

Recent News

Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

10 large-cap stocks worst performers in last week: SMMT -23.61%, KSPI -21.66%, BMRN -16.74%, RIVN -13.26%, FDX -11.08%, BNTX -9.01%, AJG -7.17%, CHWY -6.97%, NVO -6.93%, MUSA -6.90%

Lekha Gupta

GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term

BioMarin stock dips in response to TransCon CNP data, as analysts note TransCon CNP could challenge BioMarin's Voxzogo by late 2025 due to its dosing schedule and potential safety benefits.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Biomarin Pharmaceutical Inc.

Sector

Health Care

Industry

Biotechnology

BioMarin's focus is on rare-disease therapies. Genzyme markets Aldurazyme through its joint venture ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Biomarin Pharmaceutical (BMRN) stock?

You can purchase shares of Biomarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.

View our list of the best stock brokerages

Who are Biomarin Pharmaceutical (BMRN) competitors?

Other companies in Biomarin Pharmaceutical’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Biomarin Pharmaceutical (BMRN) stock?

There is no analysis for Biomarin Pharmaceutical to provide a consensus price target.

What is the current price for Biomarin Pharmaceutical (BMRN)?

The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $70.69 last updated September 20, 2024 at 4:39 PM EDT.

Does Biomarin Pharmaceutical (BMRN) pay a dividend?

There are no upcoming dividends for Biomarin Pharmaceutical.

When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?

Biomarin Pharmaceutical’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Is Biomarin Pharmaceutical (BMRN) going to split?

There is no upcoming split for Biomarin Pharmaceutical.

What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?

Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now